ANGELA SMITH: Open Payments
NPI 1427508217 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 53 payments from 12 companies in 2025. Trend: 2023 $842 · 2024 $830 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $288 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $142 |
| Ardelyx, Inc. | 8 | $133 |
| Janssen Biotech, Inc. | 3 | $52 |
| Madrigal Pharmaceuticals | 2 | $45 |
| Aimmune Therapeutics, Inc. | 3 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 3 | $26 |
| GENZYME CORPORATION | 1 | $23 |
Products named: RINVOQ, IBSRELA, LINZESS, ENTYVIO, TREMFYA, REZDIFFRA, ZENPEP, XIFAXAN.
Industry payments across FL — which companies pay providers there.
